Dragan Cicic
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Dragan Cicic is currently a Member at the American Society of Hematology and Chief Development Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. since 2024.
Former positions include Director, Chief Operating & Medical Officer at Actinium Pharmaceuticals, Inc. (2012–2013), Project Director at QED Technologies International, Inc., Chief Operating & Medical Officer at Cactus Ventures, Inc. (2012–2013), Principal at British Broadcasting Corp., Chief Technology Officer at Actinium Pharmaceuticals, Inc. (2017), and Senior Vice President at KLUS Pharma, Inc. Education includes a doctorate from the University of Belgrade, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the School of Medicine (RS).
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2026 | 126.443 ( 0,07% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Corporate Officer/Principal | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Algemeen Directeur | - |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Hoofd Techniek/Wetenschap/O&O | 18-04-2013 |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Operationeel Directeur | 18-04-2013 |
KLUS Pharma, Inc.
KLUS Pharma, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel and safer antibody-based therapeutics | Corporate Officer/Principal | - |
British Broadcasting Corp.
British Broadcasting Corp. BroadcastingConsumer Services Provides television and radio broadcasting & digital media services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
British Broadcasting Corp.
British Broadcasting Corp. BroadcastingConsumer Services Provides television and radio broadcasting & digital media services | Consumer Services |
University of Belgrade
University of Belgrade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Technologies International, Inc.
QED Technologies International, Inc. SemiconductorsElectronic Technology Develops polishing and metrology technology for semiconductors | Electronic Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
School of Medicine (RS)
School of Medicine (RS) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
KLUS Pharma, Inc.
KLUS Pharma, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel and safer antibody-based therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau